CTRI/2020/04/024859
Not yet recruiting
未知
To Study the Clinical characteristics and treatment Outcome of COVID-19 Patients admitted in hospitals of Max Healthcare (SCOPe Study) - SCOPe
Max Super Speciality Hospital A Unit of Devki Devi Foundation0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Max Super Speciality Hospital A Unit of Devki Devi Foundation
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients of either sex aged \>\=18 years
- •Patients who are Covid\-19 positive
- •All patients with positive Corona virus infection admitted in the hospitals of Max Healthcare will be included in the study.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study to investigate the characteristics of symptom recurrence after discontinuing treatment compared to continuation of treatment in patients with Irritable Bowel Syndrome with constipation (C-IBS) who responded favorably to treatment with tegaserod, a partial agonist of the 5-HT4 receptor-K589 Irritable bowel syndrome without diarrhoeaIrritable bowel syndrome without diarrhoeaK589PER-016-01OVARTIS BIOSCIENSES PERU S.A.,
Recruiting
Not Applicable
A study of the diagnosis, examination, and therapeutic strategy for gastric submucosal tumorsolid submucosal tumor of the stomach whose diameter is 2cm or lessJPRN-UMIN000013315Japan Gastroenterological Endoscopy Society5,000
Recruiting
Not Applicable
Clinical characteristics, diagnosis and treatments of Pediatric Nystagmusystagmus in childhoodTCTR20201022002one315
Not yet recruiting
Not Applicable
A study on the clinical characteristics including severity of pulmonary fibrosis by COVID-19Certain infectious and parasitic diseasesKCT0006312Asan Medical Center100
Not yet recruiting
Not Applicable
A study to compare Indian heart failure patients with and without diabetesCTRI/2017/07/009069Cipla2,500